在癌细胞中,PEG-ASO结合物可有效地向传递和抑制癌细胞迁移
Chunhui Zhao1, Xiangjun Li1, Zixin He1
1Hunan Huateng Pharmaceutical Co, Ltd., Changsha 410000, China; Changsha Institute of Innovative Pharmaceutical Industry, Changsha, 410000, China.
Bioorganic & medicinal chemistry letters
|March 26, 2025
概括
叶酸结合反感性寡核酸 (ASO) 显示瘤细胞吸收和基因沉默的增强. 这种叶酸-PEG-ASO平台为癌症治疗提供了一个有前途的策略.
科学领域:
- 生物技术是生物技术.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 反感性寡核酸 (ASO) 通过向特定的RNA来抑制癌细胞生长.
- 聚乙烯甘醇 (PEG) 修改增强了ASO的稳定性,但在瘤细胞的特异性和吸收方面存在挑战.
- 针对特定的癌细胞机制对于有效的ASO疗法至关重要.
研究的目的:
- 为增强瘤细胞向开发和评估叶酸 (FA) 和maleimide联合修改的PEG结合抗miRNA-21ASO (FA-PEG-ASO).
- 评估FA-PEG-ASO在癌细胞中的细胞吸收,目标裂解效率和抗迁移作用.
主要方法:
- 合成FA和maleimide联合修饰的PEG.
- 修改PEG与通过提-马莱胺迈克尔添加的提修改抗miRNA-21 ASO的结合.
- 通过去除三-2-碳氧乙基) 氨酸化物 (TCEP) 来优化结合制剂的制备.
- 使用细胞成像来比较FA-PEG-ASO与对照HO-PEG-ASO的细胞吸收研究.
- 对点RNA裂变和瘤细胞迁移抑制的评估.
主要成果:
- 成功合成了FA-PEG-ASO,而TCEP的去除对于高产量至关重要.
- 细胞成像显示,与对照HO-PEG-ASO相比,FA-PEG-ASO的内部化程度大约是5倍.
- FA-PEG-ASO表现出增强的抗miRNA-21点裂变.
- FA-PEG-ASO显著降低了瘤细胞迁移的能力.
结论:
- 与未经修改的PEG-ASO相比,FA-PEG-ASO显示出优越的细胞吸收和增强的治疗效果.
- FA-PEG-ASO结合体代表了癌症治疗的有前途的向治疗平台.
- 需要进一步研究FA-PEG-ASO在临床前癌症模型中的疗效.
更多相关视频
08:35Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
Published on: January 4, 2012
28.0K
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.6K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
